|Articles|April 19, 2022
THREAD Acquires CureClick
Acquisition to accelerate enrollment, improve diversity, and enhance patient experience in DCTs.
Advertisement
THREAD® announced that it has acquired CureClick. Headquartered in Costa Mesa, Calif., CureClick offers a crowdsourcing platform designed to accelerate awareness and participation in clinical research. CureClick follows THREAD's recent acquisitions of Modus Outcomes and inVibe.
Read more about this acquisition
Newsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Advertisement
Related Articles
Operational Strategies That Strengthened the NIMBLE Trial DesignSeptember 16th 2025
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
Merck Reports Strong Phase II Results for Ifinatamab Deruxtecan in Extensive-Stage Small Cell Lung Cancer
2
Phase IV Trial Shows Daybue Demonstrates Real-World Behavioral Improvements in Rett Syndrome
3
ACT Brief Weekly Recap: How AI, eClinical Innovation, and Policy Shifts Are Reshaping Clinical Research
4
Atom Therapeutics Launches Global Phase II Trial of Novel Anti-Inflammatory Treatment for Acute Gout Flares
5
.png "BioPharm International")
.png "Pharmaceutical Commerce"){kind=logo}
.png "Turbo Machinery Magazine")
.png){kind=spacer}
